USA - NASDAQ:ENVB - US29405E4061 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ENVB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-30 | HC Wainwright & Co. | Initiate | Buy |
| 2022-06-01 | Alliance Global Partners | Initiate | Buy |
| 2022-03-08 | Aegis Capital | Downgrade | Buy -> Hold |
| 2021-07-08 | Aegis Capital | Initiate | Buy |
| 2021-06-28 | Maxim Group | Initiate | Buy |
7 analysts have analysed ENVB and the average price target is 122.4 USD. This implies a price increase of 1995.89% is expected in the next year compared to the current price of 5.84.
The consensus rating for ENVERIC BIOSCIENCES INC (ENVB) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ENVERIC BIOSCIENCES INC (ENVB) is 7.